Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Sarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Positron-Emission Tomography Medicine & Life Sciences
Ewing's Sarcoma Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1997 2024

Research Output 1989 2017

2 Citations

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Tap, W. D. , Papai, Z. , Van Tine, B. A. , Attia, S. , Ganjoo, K. N. , Jones, R. L. , Schuetze, S. , Reed, D. , Chawla, S. P. , Riedel, R. F. , Krarup-Hansen, A. , Toulmonde, M. , Ray-Coquard, I. , Hohenberger, P. , Grignani, G. , Cranmer, L. D. , Okuno, S. , Agulnik, M. , Read, W. , Ryan, C. W. & 8 others Alcindor, T., del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P. Aug 1 2017 In : The Lancet Oncology. 18, 8, p. 1089-1103 15 p.

Research output: Research - peer-reviewArticle

Sarcoma
Doxorubicin
TH 302
Therapeutics
Survival

Next generation sequencing of extraskeletal myxoid chondrosarcoma

Davis, E. J., Wu, Y. M., Robinson, D., Schuetze, S. M., Baker, L. H., Athanikar, J., Cao, X., Kunju, L. P., Chinnaiyan, A. M. & Chugh, R. 2017 In : Oncotarget. 8, 13, p. 21770-21777 8 p.

Research output: Research - peer-reviewArticle

Extraskeletal Myxoid Chondrosarcoma
Sarcoma
Neoplasms
Transcriptome
sunitinib
1 Citations

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Tawbi, H. A. , Burgess, M. , Bolejack, V. , Van Tine, B. A. , Schuetze, S. M. , Hu, J. , D'Angelo, S. , Attia, S. , Riedel, R. F. , Priebat, D. A. , Movva, S. , Davis, L. E. , Okuno, S. H. , Reed, D. R. , Crowley, J. , Butterfield, L. H. , Salazar, R. , Rodriguez-Canales, J. , Lazar, A. J. , Wistuba, I. I. & 4 others Baker, L. H., Maki, R. G., Reinke, D. & Patel, S. Nov 1 2017 In : The Lancet Oncology. 18, 11, p. 1493-1501 9 p.

Research output: Research - peer-reviewArticle

Sarcoma
Bone and Bones
pembrolizumab
Therapeutics
Liposarcoma

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

Higham, C. S. , Steinberg, S. M. , Dombi, E. , Perry, A. , Helman, L. J. , Schuetze, S. M. , Ludwig, J. A. , Staddon, A. , Milhem, M. M. , Rushing, D. , Jones, R. L. , Livingston, M. , Goldman, S. , Moertel, C. , Wagner, L. , Janhofer, D. , Annunziata, C. M. , Reinke, D. , Long, L. , Viskochil, D. & 2 others Baker, L. & Widemann, B. C. 2017 In : Sarcoma. 2017, 8685638

Research output: Research - peer-reviewArticle

Neurofibromatosis 1
Neurilemmoma
Drug Therapy
Ifosfamide
Etoposide